doxycycline shortage 2013
In 2013, the pharmaceutical industry faced a significant shortage of doxycycline, an antibiotic commonly used for treating various bacterial infections and some skin conditions like acne. This shortage was primarily due to manufacturing issues at several major suppliers, which led to disruptions in production. The scarcity affected healthcare providers across different regions, making it challenging to prescribe this medication routinely. As a result, clinicians had to explore alternative antibiotics, often with less favorable side-effect profiles or higher costs. The FDA and pharmaceutical companies worked collaboratively to address the shortage by increasing production capacity at unaffected sites and importing doxycycline from international suppliers. Despite these measures, patients and healthcare providers alike felt the impact of this scarcity for several months before supplies stabilized.
